The global contract research organization market value reached $39 billion in 2018 and is expected to exceed $51bn billion by 2024. The market is becoming competitive with large CROs going for acquisitions and mergers to increase the portfolio and reach, whereas small and medium CROs are becoming more prominent with their personalized approach, contact flexibility, […]

Read More →

Do you know any product segment, where one does not get to encounter Chinese products? Well, hardly any. It has been the focus of Chinese government for the past several decades to dominate various industrial sectors, including pharmaceuticals. While, China has been the big production factory for generic drugs and API ingredients for many years, […]

Read More →

The development of drugs in rare diseases provides great opportunities to pharma companies along with challenges that are required to overcome during drug discovery, pre-clinical, and clinical stages of drug development. Commercially rare diseases drug development differs from traditional diseases, as there are considerably few patients to take the drug, therefore pharmaceutical companies should consider […]

Read More →

New Zealand could be an interesting choice of region for national and international organisations seeking to pursue clinical research  and looking for most preferred destination in Asia-Pacific Region. New Zealand, a country named third most beautiful country in the world with stunning and diverse natural beauty, jagged mountains, is full of islands with one of Earth’s most […]

Read More →

What do you call a country with quality research facilities, efficient ethics, and regulatory framework, diverse participant recruitment pool, research tax incentives and flexibility in conducting research? Some call it a dream destination, others Australia! It’s a country that has the world’s best researchers and health professionals, boasts a world-class research infrastructure and high standards […]

Read More →

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum. Globally, colorectal cancer is the third most common type of cancer in both men and women making up about 10% of all cases. Currently, there is a significant focus on development of drugs for […]

Read More →

Alopecia is a condition in which hairs are lost from some or all areas of the body. In fact, alopecia areata is also known as spot baldness for this reason. Most commonly, patients have bald spots on their scalps about the size of a coin. There are three (3) well-known types of Alopecia Alopecia areata […]

Read More →

South Korea is a well-reputed country with lots of years of clinical research to its credit. In fact, it has a long history of conducting global clinical trials than most other Asian countries including Japan. More than 80% of clinical trials conducted in South Korea are global, which is a great indicator of the suitability of […]

Read More →

Poland is regarded as one of the largest clinical trials markets in CEE/CIS. In a report in 2010, PriceWaterhouseCoopers (PwC) pointed out that with 469 new clinical trial registrations in 2009, Poland accounted for c. 2.5%-3.0% of the world market by registration volumes. Current status of clinical research in Poland The status of clinical research has […]

Read More →

The United States has consistently emerged as a leading site for clinical research. Clinicaltrials.gov registry, which serves as an effective reference to see clinical trials conducted worldwide, provides an interesting statistics regarding U.S. clinical trials. Clinical trials statistics in the U.S. A glimpse into the studies registered between 2011 and 2013 and further between 2014 […]

Read More →